CTRI/2022/03/041318尚未招募2 期
A Randomised Control trial of Shunthyadi Tail Nasya in Bhrushakshava with special Reference to Allergic Rhinitis
Self Seema Bhoyar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient suffering from allergic Rhinitis
- •2.patients of age >18 years to 60 years will be selected irrespective of their gender, caste,religion, socio- economic or educational status
- •3.patients who are ready to accept the treatment will be selected
排除标准
- •1.recurrent Rhinitis
- •2.formation of nasal polyp, tumor etc.
- •3.bronchial asthma
- •4.highly deviated nasal septum
- •5.infectious disease like T.B. and other systemic disorders which interfere in the course of treatment
研究者
相似试验
进行中（未招募）
1 期
A phase 3 study of parsaclisib plus ruxolitinib in patients with myelofibrosismyelofibrosisMedDRA version: 20.0Level: PTClassification code 10028537Term: MyelofibrosisSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-003415-98-HUIncyte Corporation212
进行中（未招募）
1 期
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Heterozygous Familial HypercholesterolemiaEUCTR2017-001903-60-DESanofi-aventis recherche & développement500
进行中（未招募）
1 期
A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Risperidone Long-Acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar I Disorder, with Open-Label ExtensioBIPOLAR MANIAEUCTR2004-003781-14-ESJohnson and Johnson Pharmaceutical Research and Development, una división de Janssen-Cilag, S.A
进行中（未招募）
1 期
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)Extensive Stage Small Cell Lung Cancer (ED SCLC)EUCTR2016-003503-64-GBAbbvie Deutschland GmbH & Co. KG748
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT 126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsMedDRA version: 15.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852Alzheimer's DiseaseEUCTR2011-004849-40-DEAbbVie Deutschland GmbH & Co. KG420